BioCentury
ARTICLE | Financial News

Life sciences investor Arix planning L100M listing

February 2, 2017 11:35 PM UTC

Investment firm Arix BioScience plc (London, U.K.) plans to raise L100 million ($125.1 million) in an IPO on the London Stock Exchange underwritten by Jefferies. The firm intends to invest in both start-up and later-stage healthcare and life science companies worldwide.

Arix’s portfolio already includes five companies: Autolus Ltd. (London, U.K.), Depixus S.A.S. (Paris, France), OptiKira LLC (Cleveland, Ohio), Verona Pharma plc (LSE:VRP) and Artios Pharma Ltd. (Cambridge, U.K.). ...